Novonesis (Novozymes) A/S
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as protein solutions and … Read more
Novonesis (Novozymes) A/S (NSIS-B) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.043x
Based on the latest financial reports, Novonesis (Novozymes) A/S (NSIS-B) has a cash flow conversion efficiency ratio of 0.043x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr466.58 Million) by net assets (Dkr10.74 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Novonesis (Novozymes) A/S - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Novonesis (Novozymes) A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Novonesis (Novozymes) A/S Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novonesis (Novozymes) A/S ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tyson Foods Inc
NYSE:TSN
|
0.029x |
|
West Pharmaceutical Services Inc
NYSE:WST
|
0.079x |
|
Sandoz Group AG
OTCQX:SDZXF
|
0.005x |
|
Las Vegas Sands Corp
NYSE:LVS
|
0.623x |
|
Centene Corp
NYSE:CNC
|
0.022x |
|
Yum China Holdings Inc
NYSE:YUMC
|
0.076x |
|
Global Payments Inc
NYSE:GPN
|
0.033x |
|
Tbea Co Ltd
SHG:600089
|
0.017x |
Annual Cash Flow Conversion Efficiency for Novonesis (Novozymes) A/S (2002–2024)
The table below shows the annual cash flow conversion efficiency of Novonesis (Novozymes) A/S from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Dkr11.18 Billion | Dkr1.02 Billion | 0.091x | -68.46% |
| 2023-12-31 | Dkr14.35 Billion | Dkr4.15 Billion | 0.289x | +2.76% |
| 2022-12-31 | Dkr14.23 Billion | Dkr4.01 Billion | 0.282x | -15.39% |
| 2021-12-31 | Dkr12.21 Billion | Dkr4.06 Billion | 0.333x | -14.08% |
| 2020-12-31 | Dkr11.24 Billion | Dkr4.36 Billion | 0.387x | +39.12% |
| 2019-12-31 | Dkr11.48 Billion | Dkr3.20 Billion | 0.278x | -13.45% |
| 2018-12-31 | Dkr11.44 Billion | Dkr3.68 Billion | 0.322x | -10.80% |
| 2017-12-31 | Dkr11.27 Billion | Dkr4.06 Billion | 0.361x | +10.30% |
| 2016-12-31 | Dkr11.74 Billion | Dkr3.84 Billion | 0.327x | +13.52% |
| 2015-12-31 | Dkr11.59 Billion | Dkr3.34 Billion | 0.288x | -28.20% |
| 2014-12-31 | Dkr11.28 Billion | Dkr4.53 Billion | 0.401x | +70.80% |
| 2013-12-31 | Dkr11.07 Billion | Dkr2.60 Billion | 0.235x | -18.52% |
| 2012-12-31 | Dkr9.57 Billion | Dkr2.76 Billion | 0.288x | -6.11% |
| 2011-12-31 | Dkr8.82 Billion | Dkr2.71 Billion | 0.307x | +3.51% |
| 2010-12-31 | Dkr7.84 Billion | Dkr2.32 Billion | 0.297x | -4.50% |
| 2009-12-31 | Dkr5.85 Billion | Dkr1.82 Billion | 0.311x | -18.09% |
| 2008-12-31 | Dkr4.48 Billion | Dkr1.70 Billion | 0.379x | -18.89% |
| 2007-12-31 | Dkr3.67 Billion | Dkr1.71 Billion | 0.467x | +3.39% |
| 2006-12-31 | Dkr3.39 Billion | Dkr1.53 Billion | 0.452x | +29.36% |
| 2005-12-31 | Dkr3.79 Billion | Dkr1.33 Billion | 0.349x | +5.69% |
| 2004-12-31 | Dkr3.89 Billion | Dkr1.29 Billion | 0.331x | +0.48% |
| 2003-12-31 | Dkr4.17 Billion | Dkr1.37 Billion | 0.329x | +18.38% |
| 2002-12-31 | Dkr4.25 Billion | Dkr1.18 Billion | 0.278x | -- |